Provided by Tiger Trade Technology Pte. Ltd.

CalAtlantic

53.12
0.0000
Volume:- -
Turnover:- -
Market Cap:6.09B
PE:14.76
High:53.12
Open:53.12
Low:53.12
Close:53.12
52wk High:64.60
52wk Low:33.56
Shares:114.62M
Float Shares:- -
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.60
ROE:--
ROA:--
PB:1.41
PE(LYR):- -

Loading ...

Iran Reopens Airspace Following Five-Hour Closure Amid Brewing Tensions With Trump

Benzinga_recent_news
·
Jan 15

Embracing Green Mountains and Clear Waters: "Green Mountains & Beautiful China Tour" Ecological Culture Campaign Launches in Lanzhou

Deep News
·
Dec 11, 2025

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025

GlobeNewswire
·
Dec 04, 2025

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

GlobeNewswire
·
Dec 03, 2025

Massive Airport Expansion Approved with 460 Billion Yuan Investment

Deep News
·
Nov 30, 2025

Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

GlobeNewswire
·
Nov 25, 2025

Eastern Airways: UK regional airline suspends operations

cityam
·
Oct 28, 2025

Future Echoes -- Where Art Meets Technology

prnewswire
·
Oct 28, 2025

LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”

GlobeNewswire
·
Oct 14, 2025

Viasat Working with Skyrora on Upcoming Mission After UK Grants Launch License

GlobeNewswire
·
Oct 01, 2025

Joby Aviation Skyrocketed Today -- Is the Stock a Buy Right Now?

Motley Fool
·
Sep 20, 2025

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

GlobeNewswire
·
Sep 03, 2025

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease

GlobeNewswire
·
Aug 30, 2025

AgEagle Aerial Systems Colombian Partner Secures Certification for eBee VISION Training

GlobeNewswire
·
Aug 26, 2025

Forum Registration Now Open - Secure Your Seat! Decoding Embodied Intelligence Implementation Challenges and Industry Opportunities

Deep News
·
Aug 20, 2025

AgEagle Aerial Systems and Drummond Ltd. Pioneer Advanced Drone Operations in Colombia

GlobeNewswire
·
Aug 19, 2025